We write to express concern about errors in a recent paper by Berridge et al. [1], and request that these be corrected.There is always scope for discussion about historical processes and how they should be interpreted. It is, however, disappointing that so much of the information in relation to both Australia and ourselves is wrong or misleading.The authors write that: 'Mike Daube and Simon Chapman… have publicly supported the sales ban on ENDS', albeit without providing any references. This significantly misrepresents the position we have both taken from the outset of policy debate about electronic nicotine delivery systems (ENDS). We have consistently been scrupulous in arguing for appropriate ENDS regulation. We have argued that final decisions should be left to the Therapeutic Goods Administration (TGA), and we have supported the TGA's decision to enable access subject to specific conditions. We have emphasized that this is not to be equated with calling for a ban. For example, in our submission to the recent Senate Committee on Tobacco Harm Reduction, we wrote: 'We have noted much commentary in which the proposed TGA via prescription proposal is described as a "ban" on nicotine vaping in Australia. This is palpable nonsense. The proposal is no more a ban on vapable nicotine than the TGA scheduling of all prescribed drugs is a "ban" on accessing the vast array of prescription medicines that are used every day by millions of Australians who have obtained authority to do so by their doctor'. We made similar comments to a 2017 Parliamentary Inquiry [2,3].They wrongly assert that ' ASH opposed tobacco harm reduction in the 1970s (under Mike Daube)'. I (MD) was